RT Journal Article
SR Electronic
T1 International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 959
OP 960
DO 10.3899/jrheum.160114
VO 43
IS 5
A1 Merola, Joseph F.
A1 Armstrong, April W.
A1 Saraiya, Ami
A1 Latella, John
A1 Garg, Amit
A1 Callis Duffin, Kristina
A1 Gottlieb, Alice B.
YR 2016
UL http://www.jrheum.org/content/43/5/959.abstract
AB Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.